ArticleMultiple sclerosis and related disorders2022

Persistently reduced humoral and sustained cellular immune response from first to third SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients.

Hamza Mahmood Bajwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.